Clinical outcome of patients with major bleeding after venous thromboembolism: Findings from the RIETE registry

Thrombosis and Haemostasis

Volumn 100, Issue 5, 2008, Pages 789-796

  Nieto, José Antonio ^a   Camara, Timoteo ^a   Gonzalez Higueras, Elena ^a   Ruiz Gimenez, Nuria ^b   Guijarro, Ricardo ^c   Marchena, Pablo Javier ^d   Monreal, Manuel ^e  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d Hospital de Sant Boi   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anticoagulant therapy; Major bleeding; Outcome; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL DECISION MAKING; CONTROLLED STUDY; DRUG FATALITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; GENITAL BLEEDING; HEMATOMA; HEMATURIA; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX RATIO; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARGENTINA; EUROPE; FEMALE; HEMORRHAGE; HUMANS; ISRAEL; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY EMBOLISM; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM;

EID: 55549148457     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-06-0390     Document Type: Article

References (23)

1. th Edition). Chest 2008; 133: 454-545.
2. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-152.
3. Kuijer PM, Hutten BA, Prins MH, et al. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 1999; 159: 457-460.
4. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139: 893-900.
5. Falgà C, Capdevila JA, Soler S, et al., for the RIETE Investigators. Clinical Outcome of Patients with Venous Thromboembolism and Renal Insufficiency. Findings from the RIETE Registry. Thromb Haemost 2007; 98: 771-776.
6. Blanco-Molina A, Trujillo-Santos J, Criado J, et al., and the RIETE Investigators. Venous Thrombo-embolism during pregnancy or postpartum: Findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.
7. Arcelus JI, Monreal M, Caprini JA, et al., and the RIETE investigators. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost 2008; 99: 546-551.
8. Nieto JA, Bruscas MJ, Ruiz-Ribo D, et al.; for the RIETE Investigators. Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome. J Thromb Haemost 2006; 4: 2367-2372.
9. Ruiz-Giménez N, Suárez C, González R, et al., and the RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
11. Landefeld CS, Beyth R. Anticoagulation-related bleeding: Clinical epidemiology, prediction and prevention. Am J Med 1993; 95: 315-328.
12. Gitter MJ, Jaeger TM, Petterson TM, et al. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clin Proc 1995; 70: 725-733
13. Van de Meer FJM, Rosendaal FR, Vandenbroucke JP, et al. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 1557-1562.
14. White RH, McKittrick T, Takakuwa J, et al., and the National Consortium of Anticoagulation Clinics. Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med 1996; 156: 1197-1201.
15. Landefeld CS, Cook EF, Flatley M, et al. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987; 82: 703-713.
16. Landefeld CS, Rosenblatt MB, Goldman L. Bleeding in outpatients treated with warfarin: Relation to the prothrombin time and important remediable lesions. Am J Med 1989; 87: 153-159.
17. McMahan DA, Smith DM, Carey MA, et al. Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med 1998; 13: 311-316.
18. White RH, Beyth RJ, Zhou H, et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 1999; 107: 414-424.
19. Zidane M, Schram T, Planken EW, et al. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism. A Study in routine clinical practice. Arch Intern Med 2000; 160: 2369-2373.
20. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-3488.
21. Bigaroni A, Perrier P, de Moerloose P, et al. Risk of major bleeding in unselected patients with venous thromboembolism. Blood Coag Fibrinol 2000; 11: 199-202.
22. Kucher N, Rossi E, de Rosa M, et al. Massive pulmonary embolism. Circulation 2006; 113: 577-582.
23. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-415.